|
Human Tumor Atlas Network: Data Coordinating Center
|
1U24CA233243-01
|
$14,488,060
|
|
CERAMI, ETHAN
|
DANA-FARBER CANCER INST
|
|
Minority PDX Development and Trial Center: Baylor College of Medicine and MD Anderson Cancer Center Collaboration on Mechanistic Studies to Dissect and Combat Health Disparities in Cancer
|
1U54CA233223-01
|
$6,353,982
|
|
MITSIADES, NICHOLAS
|
BAYLOR COLLEGE OF MEDICINE
|
|
Immuno-Oncology Translation Network: Data Management and Resource-Sharing Center at RPCI
|
1U24CA232979-01
|
$6,276,836
|
|
HUTSON, ALAN
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Blood and Marrow Transplant Clinical Trials Network Data Coordinating Center
|
5U24HL138660-02
|
$3,900,000
|
|
HOROWITZ, MARY
|
MEDICAL COLLEGE OF WISCONSIN
|
|
AIDS and Cancer Specimen Resource (ACSR)
|
3UM1CA181255-05S1
|
$3,000,000
|
|
MCGRATH, MICHAEL
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Coordinating Center for Research Centers for Improving Management of Symptoms During and Following Cancer Treatment
|
1U24CA232980-01
|
$2,949,346
|
|
KRONER, BARBARA
|
RESEARCH TRIANGLE INSTITUTE
|
|
ASPirin in Reducing Events in the Elderly
|
3U01AG029824-07S2
|
$2,820,000
|
|
MURRAY, ANNE
|
MINNEAPOLIS MEDICAL RESEARCH FDN, INC.
|
|
Mayo Clinic Multiple Myeloma SPORE
|
5P50CA186781-04
|
$2,538,499
|
|
BERGSAGEL, PETER
|
MAYO CLINIC ARIZONA
|
|
Innovative Infrastructure to Enhance the California Teachers Study
|
5U01CA199277-04
|
$2,520,260
|
|
LACEY, JAMES
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
High-throughput in vivo genetics for immunotherapy target discovery
|
1DP2CA238295-01
|
$2,512,500
|
|
CHEN, SIDI
|
YALE UNIVERSITY
|
|
Brain Tumor SPORE Grant
|
2P50CA097257-16
|
$2,498,496
|
|
BERGER, MITCHEL
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Translational Research in Breast Cancer (SPORE)
|
5P50CA186784-04
|
$2,300,000
|
$138,000
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
DF/HCC Kidney Cancer SPORE
|
5P50CA101942-13
|
$2,300,000
|
$276,000
|
MCDERMOTT, DAVID
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
SPORE in Cervical Cancer
|
5P50CA098252-14
|
$2,300,000
|
$299,000
|
WU, TZYY-CHOOU
|
JOHNS HOPKINS UNIVERSITY
|
|
SPORE in Skin Cancer
|
5P50CA174523-04
|
$2,300,000
|
$92,000
|
HERLYN, MEENHARD
|
WISTAR INSTITUTE
|
|
SPORE: Developing New Rationale, Personalized Medicine for Lung Cancer
|
5P50CA070907-19
|
$2,299,998
|
$460,000
|
MINNA, JOHN
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
Extending Chimeric Antigen (CAR) T cell therapy to thoracic cancers
|
1P01CA217805-01A1
|
$2,105,511
|
|
ALBELDA, STEVEN
|
UNIVERSITY OF PENNSYLVANIA
|
|
Molecular Diagnosis, Prognosis, and Therapeutic Targets in Lymphoma
|
1P01CA229100-01
|
$2,087,361
|
|
RIMSZA, LISA
|
MAYO CLINIC ARIZONA
|
|
SPORE in Prostate Cancer
|
5P50CA058236-22
|
$1,993,426
|
$398,685
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer: Coordinating and Data Management Center (CSCPDPC-CDMC)
|
5U01DK108328-04
|
$1,900,000
|
|
YUAN, YING
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Circumventing barriers to effective oncolytic virotherapy of malignant gliomas
|
2P01CA163205-06A1
|
$1,889,731
|
|
CHIOCCA, E
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Protein Kinase Therapeutic Targets for Non-Small Cell Lung Carcinoma
|
5P01CA154303-07
|
$1,846,173
|
|
MEYERSON, MATTHEW
|
DANA-FARBER CANCER INST
|
|
Comparative Modeling: Informing Breast Cancer Control Practice and Policy
|
5U01CA199218-04
|
$1,740,652
|
|
MANDELBLATT, JEANNE
|
GEORGETOWN UNIVERSITY
|
|
TCIA Sustainment and Scalability - Platforms for Quantitative Imaging Informatics in Precision Medicine
|
5U24CA215109-02
|
$1,667,436
|
|
PRIOR, FRED
|
UNIV OF ARKANSAS FOR MED SCIS
|
|
Adoptive Cell Transfer Immunotherapy of Cancer
|
ZIA BC 010984
|
$1,629,581
|
$651,832
|
Rosenberg, Steven
|
CCR (NCI)
|
|
Gene therapy of cancer
|
ZIA BC 010985
|
$1,629,581
|
$651,832
|
Rosenberg, Steven
|
CCR (NCI)
|
|
Building on the success of the adoptive immunotherapy of cancer
|
ZIA BC 010763
|
$1,562,883
|
$390,721
|
Restifo, Nicholas
|
CCR (NCI)
|
|
HIV integration-mediated modulation of immune regulation in HPV-associated cancers
|
5R01CA206466-03
|
$1,434,093
|
|
FRENKEL, LISA
|
SEATTLE CHILDREN'S HOSPITAL
|
|
Consortium for large-scale production and phenotyping of knockout mice (UM1)
|
5UM1HG006348-08
|
$1,260,000
|
|
BEAUDET, ARTHUR
|
BAYLOR COLLEGE OF MEDICINE
|
|
Diesel Exhaust in Miners Study II
|
ZIA CP010120 10762
|
$1,229,164
|
|
Silverman, Debra
|
DCEG (NCI)
|
|
Integrated Molecular, Cellular, and Imaging Characterization of Screen-Detected Lung Cancer
|
5U01CA196408-04
|
$1,218,395
|
|
DUBINETT, STEVEN
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Epi-genetic Programs in Cancer Progression
|
5R35CA220487-02
|
$1,170,000
|
|
WEINBERG, ROBERT
|
WHITEHEAD INSTITUTE FOR BIOMEDICAL RES
|
|
Development of PEGylated MTI-101 for the treatment of relapsed Myeloma
|
4R44CA221554-02
|
$1,161,570
|
|
WATERHOUSE, RIKKI
|
MODULATION THERAPEUTICS, INC.
|
|
Accelerated discovery of methylation targeted therapeutic development
|
2R44CA212733-02
|
$1,148,788
|
|
SUN, ZU-WEN
|
EPICYPHER, INC.
|
|
Precision Interception of Aggressive Prostate Cancer in African American Men
|
1P20CA233255-01
|
$1,083,300
|
|
REBBECK, TIMOTHY
|
DANA-FARBER CANCER INST
|
|
Membrane-based vaccine with checkpoint blockade for triple negative breast cancer
|
5R44CA221559-02
|
$1,079,344
|
|
KANNAN, KAMAL
|
METACLIPSE THERAPEUTICS CORPORATION
|
|
Monitoring immune response to immunotherapies in cancer patients with VisAcT PET tracer
|
5R44CA221624-02
|
$1,020,835
|
|
LEVI, JELENA
|
CELLSIGHT TECHNOLOGIES, INC.
|
|
Targeting Epigenetic Circuits in B-Cell Lymphomas
|
1R35CA220499-01A1
|
$1,017,000
|
|
MELNICK, ARI
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
PTEN and Cancer
|
5R35CA220491-02
|
$1,011,974
|
|
PARSONS, RAMON
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
Stem Cell Biology, Cancer Stem Cell Biology, and Cancer Immunotherapy
|
5R35CA220434-02
|
$1,010,214
|
|
WEISSMAN, IRVING
|
STANFORD UNIVERSITY
|
|
Functional Genomic Discovery of Pathway Targeted and Immune Modulatory Therapeutic Combinations in Hematologic Malignancies
|
5U01CA217862-02
|
$1,004,844
|
|
DRUKER, BRIAN
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
Household Air Pollution and Health: A Multi-Country LPG Intervention Trial
|
5UM1HL134590-03
|
$1,000,000
|
|
CLASEN, THOMAS
|
EMORY UNIVERSITY
|
|
SQSTM1/p62-targeted Small Molecules for Multiple Myeloma Disease
|
4R44CA210882-02
|
$1,000,000
|
|
LEE, JAMES
|
ID4PHARMA, LLC
|
|
Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer: Coordinating and Data Management Center (CSCPDPC-CDMC)
|
3U01DK108328-04S2
|
$1,000,000
|
|
YUAN, YING
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
A novel protein engineering tool for rapid manufacturing of designer nucleosomes
|
2R44CA214076-02
|
$999,997
|
|
KEOGH, MICHAEL-CHRISTOPHER
|
EPICYPHER, INC.
|
|
Novel IL-15 Superagonist Therapy for Bladder Cancer
|
6R44CA156740-05
|
$999,919
|
|
RHODE, PETER
|
ALTOR BIOSCIENCE. LLC
|
|
Clinical Development of JS-K for the Treatment of Cancer
|
5R44CA221570-02
|
$999,423
|
|
NOWOSLAWSKI, JOSEPH
|
JSK THERAPEUTICS, INC.
|
|
Detecting breast cancer with a simple blood test using an accessible and low-cost novel real-time platform
|
4R44CA217447-02
|
$996,518
|
|
THIRUPPATHI, EAGAPPANATH
|
INANOVATE, INC.
|
|
Optimization and Validation of an indicator cell assay for blood-based diagnosis of lung cancer
|
2R44CA203455-02A1
|
$996,232
|
|
SMITH, JENNIFER
|
PRECYTE, INC.
|
|
Systems Biology based Proteogenomic Translator for Cancer Marker Discovery towards Precision Medicine
|
5U24CA210993-03
|
$992,364
|
|
WANG, PEI
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
Total relevant funding to Gene Therapy Clinical Trials for this search: $6,605,745
|